Clinical Trials Logo
  1. Home
  2. Roux-en-Y Gastric Bypass
  3. NCT02173886

A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery

Roux en Y Gastric Bypass Clinical Trial

Clinical Trial Summary

This study is being conducted to evaluate how the body absorbs and processes the sustained release (SR) and extended release (XL) medication bupropion (Wellbutrin®). Subject who are 1-3 years post gastric bypass surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete two 12-hour study days approximately 11 days apart.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02173886
Study type Interventional
Source North Dakota State University
Contact
Status Completed
Phase Phase 4
Start date June 2014
Completion date February 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT00950872 - Safety and Efficacy Study of Duet TRS N/A
Recruiting NCT04237311 - Bariatric Surgery and Male Reproductive Function
Completed NCT02005107 - Venlafaxine PK Following Bariatric Surgery Phase 4